首页> 外文期刊>Drug Safety - Case Reports >Ventricular Tachycardia Triggered by Loperamide and Famotidine Abuse
【24h】

Ventricular Tachycardia Triggered by Loperamide and Famotidine Abuse

机译:洛哌丁胺和法莫替丁滥用引发室性心动过速

获取原文
       

摘要

Abstract A 32-year-old male developed recurrent ventricular tachycardia after taking mega doses of loperamide and famotidine in order to experience an opiate-like euphoric effect. He was taking up to 200?mg of loperamide and multiple doses of famotidine each day. He developed palpitations and syncope. Electrocardiography demonstrated ventricular tachycardia and QT interval prolongation (corrected QT interval was 597?ms). He was diagnosed with loperamide-induced QT prolongation resulting in incessant ventricular tachycardia. Loperamide was discontinued, and he was treated with electrolyte replacement, supportive care, and monitoring. After 5?days, his electrocardiogram (ECG) normalized and he had no more ventricular tachycardia. A Naranjo assessment score of 8 was obtained, indicating a probable relationship between QT prolongation and his use of loperamide. Large doses of loperamide can cause QT interval prolongation and life-threatening arrhythmias. These effects may be accentuated when histamine-2 receptor blockers are also abused.
机译:摘要一名32岁的男性在服用大剂量洛哌丁胺和法莫替丁后出现复发性室性心动过速,从而产生类似鸦片的欣快感。他每天服用200毫克的洛哌丁胺和多剂量的法莫替丁。他出现心和晕厥。心电图检查显示室性心动过速和QT间隔延长(校正后的QT间隔为597?ms)。他被诊断出洛哌丁胺引起的QT延长,导致持续性心室性心动过速。洛哌丁胺停用后,接受电解质替代,支持治疗和监测治疗。 5天后,他的心电图(ECG)恢复正常,不再有室性心动过速。获得的Naranjo评估得分为8,表明QT延长与他使用洛哌丁胺之间可能存在关联。大剂量洛哌丁胺会导致QT间期延长和危及生命的心律不齐。当还滥用组胺2受体阻滞剂时,这些作用可能会加剧。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号